e-learning
resources
Milan 2017
Sunday, 10.09.2017
Best clinical practice for the management of chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of depression on patients with Idiopathic Pulmonary Fibrosis
A. Tzouvelekis (Athens, Greece)
Source:
International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Session:
Best clinical practice for the management of chronic lung diseases
Session type:
Poster Discussion
Number:
357
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Tzouvelekis (Athens, Greece). Impact of depression on patients with Idiopathic Pulmonary Fibrosis. 357
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Cognitive impairment and depression in patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Treatment of Idiopathic Pulmonary Fibrosis
Source: Guideline 2015
Year: 2015
Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF).
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2014 – ILDs 5
Year: 2014
Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF)
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis?
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020
Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – M-health/e-health I
Year: 2019
Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Impact of specific organic exposure on the prognosis in Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Plasma derived-exosome microRNAs in Idiopathic Pulmonary Fibrosis of Anti-synthetase syndrome Disease patients
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016
Year: 2017
IPF - Idiopathic Pulmonary Fibrosis
Source: Breathe, 15 (2) 153; 10.1183/20734735.ELF152
Year: 2019
Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis?
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary
Source: Guideline 2015
Year: 2015
Quantitative Assessment of Thoracic Muscles in Patients with Idiopathic pulmonary fibrosis :Relationship with Prognosis
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
Cognitive impairment in patients with Idiopathic Pulmonary Fibrosis - Obstructive Sleep Apnea Overlap
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Idiopathic Pulmonary Fibrosis (IPF)
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019
Idiopathic Pulmonary Fibrosis (IPF)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019
Idiopathic Pulmonary Fibrosis (IPF)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept